Impact of FASL-induced apoptosis in the elimination of tumor cells by NK cells.

The cytotoxic effector functions of NK cells are important for enabling the immune system to cope efficiently with infection and malignancy. Two major mechanisms of cytotoxicity are perforin/granzyme- and death receptor-mediated (e.g., FASL- or TRAIL-mediated) induction of cell death. Many studies, including studies in perforin-deficient animals, have led to the conclusion that perforin/granzyme-mediated induction of cell death is a principal pathway used by NK cells to eliminate virus-infected or transformed cells. However, death receptor-mediated apoptosis may also contribute to NK cell-mediated cytotoxicity, as revealed by more recent reports. In the present paper, we have reviewed current data on death receptor-mediated tumor cell apoptosis by NK cells with a particular emphasis on the role of NK cell FASL in the RMA/RMA-S tumor model.

[1]  M. Simon,et al.  Cytotoxic T Cells Specifically Induce Fas on Target Cells, Thereby Facilitating Exocytosis-Independent Induction of Apoptosis1 , 2000, The Journal of Immunology.

[2]  T. Sayers,et al.  Tumor-Specific CTL Kill Murine Renal Cancer Cells Using Both Perforin and Fas Ligand-Mediated Lysis In Vitro, But Cause Tumor Regression In Vivo in the Absence of Perforin1 , 2002, The Journal of Immunology.

[3]  R. Zinkernagel,et al.  Perforin dependence of natural killer cell‐mediated tumor control in vivo , 1995, European journal of immunology.

[4]  L. Kaer,et al.  IFN-γ–mediated inhibition of tumor angiogenesis by natural killer T-cell ligand, α-galactosylceramide , 2002 .

[5]  J. Trapani,et al.  Granzyme A and B‐deficient killer lymphocytes are defective in eliciting DNA fragmentation but retain potent in vivo anti‐tumor capacity , 2001, European journal of immunology.

[6]  Jie-Hui Li,et al.  Tumor Immunity in Perforin-Deficient Mice: A Role for CD95 (Fas/APO-1)1 , 2000, The Journal of Immunology.

[7]  H. Ljunggren,et al.  NK Cell TRAIL Eliminates Immature Dendritic Cells In Vivo and Limits Dendritic Cell Vaccination Efficacy 1 , 2004, The Journal of Immunology.

[8]  H. Ljunggren,et al.  In search of the 'missing self': MHC molecules and NK cell recognition. , 1990, Immunology today.

[9]  R. Herberman,et al.  Natural cytotoxic reactivity of mouse lymphoid cells against syngeneic and allogeneic tumors. I. Distribution of reactivity and specificity , 1975, International journal of cancer.

[10]  K. Yoshino,et al.  Metalloproteinase-mediated Release of Human Fas Ligand , 1995 .

[11]  J. Tschopp,et al.  Viral FLICE-inhibitory proteins (FLIPs) prevent apoptosis induced by death receptors , 1997, Nature.

[12]  P. Bird.  Serpins and regulation of cell death. , 1998, Results and problems in cell differentiation.

[13]  M. Smyth,et al.  Increased Susceptibility to Tumor Initiation and Metastasis in TNF-Related Apoptosis-Inducing Ligand-Deficient Mice1 , 2002, The Journal of Immunology.

[14]  J. Schatzle,et al.  Stepwise cytoskeletal polarization as a series of checkpoints in innate but not adaptive cytolytic killing , 2003, Proceedings of the National Academy of Sciences of the United States of America.

[15]  H. Ljunggren,et al.  Selective rejection of H–2-deficient lymphoma variants suggests alternative immune defence strategy , 1986, Nature.

[16]  M. Caligiuri,et al.  What does it take to make a natural killer? , 2003, Nature Reviews Immunology.

[17]  R. Kiessling,et al.  „Natural”︁ killer cells in the mouse. I. Cytotoxic cells with specificity for mouse Moloney leukemia cells. Specificity and distribution according to genotype , 1975, European journal of immunology.

[18]  P. Parham,et al.  Variable receptors controlling activation and inhibition of NK cells. , 2002, Current opinion in immunology.

[19]  T. Saito,et al.  Fas-mediated cytotoxicity by freshly isolated natural killer cells , 1995, The Journal of experimental medicine.

[20]  M. Smyth,et al.  Critical Role for Tumor Necrosis Factor–related Apoptosis-inducing Ligand in Immune Surveillance Against Tumor Development , 2002, The Journal of experimental medicine.

[21]  J. A. Hobbs,et al.  Fas involvement in cytotoxicity mediated by human NK cells. , 1995, Cellular immunology.

[22]  H. Ljunggren,et al.  Triggering of natural killer cells by the costimulatory molecule CD80 (B7-1) , 1996, Immunity.

[23]  M. Smyth,et al.  Involvement of tumor necrosis factor-related apoptosis-inducing ligand in surveillance of tumor metastasis by liver natural killer cells , 2001, Nature Medicine.

[24]  G. Trinchieri,et al.  Biology of Natural Killer Cells , 1989, Advances in Immunology.

[25]  E. Alnemri,et al.  Natural Killer (NK) Cell–mediated Cytotoxicity: Differential Use of  TRAIL and Fas Ligand by Immature and Mature Primary Human NK Cells , 1998, The Journal of experimental medicine.

[26]  R. Welsh,et al.  Distinct organ-dependent mechanisms for the control of murine cytomegalovirus infection by natural killer cells , 1997, Journal of virology.

[27]  J. Schatzle,et al.  Inhibition of the Death Receptor Pathway by cFLIP Confers Partial Engraftment of MHC Class I-Deficient Stem Cells and Reduces Tumor Clearance in Perforin-Deficient Mice1 , 2001, The Journal of Immunology.

[28]  R. Herberman,et al.  Natural cytotoxic reactivity of mouse lymphoid cells against syngeneic and allogeneic tumors. II. Characterization of effector cells , 1975, International journal of cancer.

[29]  Judy Lieberman,et al.  Cell death and immunity: The ABCs of granule-mediated cytotoxicity: new weapons in the arsenal , 2003, Nature Reviews Immunology.

[30]  K. Kärre.  NK Cells, MHC Class I Molecules and the Missing Self , 2002, Scandinavian journal of immunology.

[31]  Margot Thome,et al.  Inhibition of death receptor signals by cellular FLIP , 1997, Nature.

[32]  H. Ljunggren,et al.  A Central Role for Death Receptor-Mediated Apoptosis in the Rejection of Tumors by NK Cells1 , 2001, The Journal of Immunology.

[33]  M. Djerbi,et al.  Characterization of the Human FLICE‐Inhibitory Protein Locus and Comparison of the Anti‐Apoptotic Activity of Four Different FLIP Isoforms , 2001, Scandinavian journal of immunology.

[34]  Y. Iwakura,et al.  Critical contribution of IFN‐γ and NK cells, but not perforin‐mediated cytotoxicity, to anti‐metastatic effect of α‐galactosylceramide , 2001 .

[35]  Mark J. Smyth,et al.  Functional significance of the perforin/granzyme cell death pathway , 2002, Nature Reviews Immunology.

[36]  P. Kuppen,et al.  Secreted and Membrane-Associated Matrix Metalloproteinases of IL-2-Activated NK Cells and Their Inhibitors1 , 2000, The Journal of Immunology.

[37]  P. Kuppen,et al.  Matrix metalloproteinases of human NK cells. , 2000, In vivo.

[38]  G. Griffiths,et al.  Degranulation plays an essential part in regulating cell surface expression of Fas ligand in T cells and natural killer cells , 1999, Nature Medicine.

[39]  H. Ljunggren,et al.  Regulation of perforin‐independent NK cell‐mediated cytotoxicity , 2003, European journal of immunology.

[40]  R. Kiessling,et al.  „Natural”︁ killer cells in the mouse. II. Cytotoxic cells with specificity for mouse Moloney leukemia cells. Characteristics of the killer cell , 1975, European journal of immunology.

[41]  J. Schatzle,et al.  Perforin‐ and Fas‐dependent mechanisms of natural killer cell‐mediated rejection of incompatible bone marrow cell grafts , 2002, European journal of immunology.

[42]  T. Whiteside,et al.  Constitutive expression and role of the TNF family ligands in apoptotic killing of tumor cells by human NK cells. , 1999, Journal of immunology.

[43]  Lewis L Lanier,et al.  Natural killer cells and cancer. , 2003, Advances in cancer research.

[44]  P. Katz,et al.  Mechanisms of human cell-mediated cytotoxicity. III. Dependence of natural killing on microtubule and microfilament integrity. , 1982, Journal of immunology.

[45]  N. Sueyoshi,et al.  Localization of Fas ligand in cytoplasmic granules of CD8+ cytotoxic T lymphocytes and natural killer cells: participation of Fas ligand in granule exocytosis model of cytotoxicity. , 2002, Biochemical and biophysical research communications.

[46]  H. Ljunggren,et al.  Host resistance directed selectively against H-2-deficient lymphoma variants. Analysis of the mechanism , 1985, The Journal of experimental medicine.

[47]  G. McFadden,et al.  Differential inhibition of the Fas- and granule-mediated cytolysis pathways by the orthopoxvirus cytokine response modifier A/SPI-2 and SPI-1 protein. , 1996, Proceedings of the National Academy of Sciences of the United States of America.

[48]  J. Krauss,et al.  T Cell-Mediated Tumor Rejection Displays Diverse Dependence Upon Perforin and IFN-γ Mechanisms That Cannot Be Predicted From In Vitro T Cell Characteristics1 , 2000, The Journal of Immunology.

[49]  J. D. Young,et al.  Morphologic and functional characterization of perforin-deficient lymphokine-activated killer cells. , 1995, Journal of immunology.

[50]  Hans Hengartner,et al.  Cytotoxicity mediated by T cells and natural killer cells is greatly impaired in perforin-deficient mice , 1994, Nature.